| | | Single nucleotide variant (missense variant +1 more) | Ovarian cancer | |
| | DDB2, LOC126861205 (E29fs) | Duplication (frameshift variant +1 more) | Xeroderma pigmentosum, group E | |
| | | Single nucleotide variant (missense variant +1 more) | Inborn genetic diseases | |
| | | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group E | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Microsatellite | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group E +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Xeroderma pigmentosum, group E | |
| | | Single nucleotide variant (5 prime UTR variant) | Xeroderma pigmentosum, group E | |
| | | Single nucleotide variant (5 prime UTR variant) | Xeroderma pigmentosum, group E | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Xeroderma pigmentosum | |
| | | Single nucleotide variant (5 prime UTR variant) | Xeroderma pigmentosum, group E | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Xeroderma pigmentosum, group E | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |